Counselors in Summit, WI Accepting Medicare
3 Counselors found. Showing 1 - 3
 Mr. Don Anthony Neumann, LPC, NCC, CSAC Counselor - Professional Medicare: Medicare Enrolled Practice Location: 36500 Aurora Dr, Summit, WI 53066 Phone: 262-434-5880 |
 Dr. Kathleen Mary Duffy, PH.D. Counselor - Professional Medicare: Accepting Medicare Assignments Practice Location: 36500 Aurora Dr, Summit, WI 53066 Phone: 262-434-5876 Fax: 262-434-5809 |
Samantha M Scherer, LPC Counselor - Professional Medicare: Medicare Enrolled Practice Location: 36500 Aurora Dr, Summit, WI 53066 Phone: 414-773-4312 |
News Archive
UTHealth's bioinformatician receives $5.8 CPRIT grant to sort out cancer data for finding cures
In keeping with the shift in cancer research from data generation to data analysis, bioinformatician W. Jim Zheng, Ph.D., of The University of Texas Health Science Center at Houston has been awarded a five-year, $5.8 million Cancer Prevention & Research Institute of Texas grant to sort out information that could lead to cancer cures.
New SMILEY tool helps assess QoL of children with lupus
A newly designed tool is helping researchers shed light on the quality of life (QoL) of children with lupus around the world, according to research presented at the American College of Rheumatology (ACR) annual meeting, held Nov. 7-11, in Atlanta.
Direct action of SARS-CoV-2 on organs may lead to exacerbated inflammatory response in pediatric patients
Besides common symptoms such as fever, cough and respiratory distress, some children have an atypical form of COVID-19 known as multisystem inflammatory syndrome in children (MIS-C), characterized by persistent fever and inflammation of several organs, such as the heart and intestines, as well as the lungs to a lesser extent.
Transcept Pharmaceuticals to discuss the Complete Response Letter for Intermezzo NDA
Transcept Pharmaceuticals, Inc. today announced that it is scheduled to meet with the U.S. Food and Drug Administration (FDA) on January 20, 2010 to discuss the Complete Response Letter regarding the New Drug Application (NDA) for Intermezzo® (zolpidem tartrate sublingual tablet). As previously announced, the Complete Response Letter, received by Transcept on October 28, 2009, indicated that the FDA could not approve the NDA in its present form.
UnitedHealth Group announces results of previously announced debt tender offers
UnitedHealth Group today announced the final results for its previously announced modified "Dutch Auction" cash tender offers for certain of its notes. The tender offers expired at 12:00 midnight, New York City time, on February 5, 2010. As of the expiration date, UnitedHealth Group received tenders for $474 million aggregate principal amount of its short-term notes and $586 million aggregate principal amount of its intermediate-term notes.
› Verified 1 days ago